BioXcel Therapeutics, Inc. (BTAIQ) Net margin 2022–2025
BioXcel Therapeutics, Inc. (BTAIQ) net profit margin by fiscal year — reported net income divided by reported revenue.
-10887.4%FY2025 · since FY2022: -44201.9% → -10887.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -10887.4% | -8257.2 pp |
| FY2024 | -2630.1% | +10344.7 pp |
| FY2023 | -12974.9% | +31227.0 pp |
| FY2022 | -44201.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BTAIQ financial trends
BTAIQ RevenueBTAIQ Net incomeBTAIQ Gross profitBTAIQ Gross marginBTAIQ Operating incomeBTAIQ Operating marginBTAIQ Operating cash flowBTAIQ Free cash flowBTAIQ Capital expendituresBTAIQ Return on equityBTAIQ Stock buybacksBTAIQ Dividends paidBTAIQ Total assetsBTAIQ Total liabilitiesBTAIQ Shareholders’ equityBTAIQ overview →